Search

Board Moves July 20, 2018

Avita Medical has expanded its management team in the commercial, legal and medical affairs functions to support the planned US launch of the RECELL® Autologous Cell Harvesting Device in the treatment

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Source: Morningstar

Total Shareholder Return as at 30/09/19

1 year TSR5 year TSR
8thAvita Medical462%47%
733 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

10/01/19
$0 Other
10/01/19
$0 Other
10/01/19
$15k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

th-Avita Medical$17.0m
77 listed non wa companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer